Search
Vistagen Therapeutics Inc
VTGNAdd to Watchlist
0.670USD
-0.020-2.87%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
27.50MMarket Cap
LossP/E TTM
Vistagen Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Vistagen Therapeutics Inc is 8.67, ranking 101 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.35, which is -98.14% below the recent high of -0.01 and -1121.34% above the recent low of -4.33.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
